Expression of HCM causing mutations: Lessons learnt from genotype-phenotype studies of the South African founder MYH7 A797T mutation [4]

Journal of Medical Genetics

Volumn 37, Issue 12, 2000, Pages 951-956

  Moolman Smook, J ^a   De Lange, W ^a   Corfield, V ^a   Brink, P ^a  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOUNDER EFFECT; GENE MUTATION; GENOTYPE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LETTER; MALE; PEDIGREE; PENETRANCE; PHENOTYPE; PRIORITY JOURNAL; SOUTH AFRICA;

ADOLESCENT; ADULT; AGED; ALANINE; AMINO ACID SUBSTITUTION; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; DEATH, SUDDEN, CARDIAC; FEMALE; FOUNDER EFFECT; GENE EXPRESSION REGULATION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION; MYOSIN HEAVY CHAINS; PEDIGREE; PHENOTYPE; PROGNOSIS; PROSPECTIVE STUDIES; SOUTH AFRICA; THREONINE;

EID: 0034533525     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (26)

1. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: Echocardiographic analysis of 4111 subjects in the CARDIA study
2. Hypertrophic cardiomyopathy
3. Sudden death due to troponin T mutations
4. Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy
5. Familial hypertrophic cardiomyopathy: From mutations to functional defects
6. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy
7. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy
8. Molecular pathology of familial hypertrophic cardiomyopathy caused by mutations in the cardiac myosin binding protein C gene
9. Clinical implications of hypertrophic cardiomyopathy associated with mutations in the alpha-tropomyosin gene
10. Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy
11. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy
12. Molecular basis of familial cardiomyopathies
13. Difference in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the β-myosin heavy chain gene: A 908 Leu-Val mutation and a 403 Arg-Gln mutation
14. Clinical and prognostic evaluation of familial hypertrophic cardiomyopathy in two South African families with different cardiac β myosin heavy chain gene mutations
15. Clinical features of hypertrophic cardiomyopathy caused by mutation of a 'hot spot' in the alpha-tropomyosin gene
16. Identification of a novel Ala797Thr mutation in exon 21 of MYH7
17. The origins of hypertrophic cardiomyopathy-causing mutations in two South African sub-populations: A unique profile of both independent and founder events
18. Polymerase chain reaction-based detection of MN blood group-specific sequences in the human genome
19. A point score system for the ECG diagnosis of left ventricular hypertrophy
20. Nonparametric estimation from incomplete observations
21. Detection of specific sequences among DNA fragments separated by gel electrophoresis
22. 5, a very informative oligonucleotide probe for DNA fingerprinting
23. The influence of the angiotensin-1 converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation
24. Idiopathic hypertrophic cardiomyopathy in identical twins. Morphological heterogeneity of the left ventricle
25. Hypertrophic cardiomyopathy in identical twins
26. Exercise-induced cardiac hypertrophy is associated with an increased myocardial compliance